|
|
Competition open to companies for the development of new or improved antibiotics, chemotherapeutics or combination preparations, as well as phage therapies used to treat bacterial infections. The aim of the competition is to finance R&D works in the field of designing and developing innovative solutions in the area of new or improved antibiotics, chemotherapeutics and medicinal products with antibacterial properties. The support provided under the competition is intended to stimulate the production and introduction of new antibiotics and chemotherapeutics to the market. This is intended to help solve the situation that is currently taking place.
when pharmaceutical companies choose other, more profitable research and production and ignore the antibiotic sector, considering activities in this area to be unprofitable. What will be financed? Developing new antibiotics or antibacterial chemotherapeutics. Modification of existing photo retouching antibiotics or chemotherapeutics. Design and development of combined preparations of several antibiotics or antibiotics with other compounds. Design and development of phage preparations. Allocation: PLN million Date of recruitment announcement: Q Individual entrepreneurs conducting scientific research and development work, as well as consortiums in which the leader is an enterprise, can take part in the competition.
Members of the consortium may include, for example, scientific institutions and medical entities (the full list of entities that may be members of the consortium is specified in Article of the Act about the Medical Research Agency). Competition for enterprises for the development or adaptation of medical devices for the needs of military medicine, with particular emphasis on battlefield medicine (ABM/ / ) The announcement of the competition is related to the growing military threat in the region of Eastern and Central-Eastern Europe, in particular the open armed conflict in Ukraine that has been ongoing since.
|
|
發表於 2023-10-11 13:33:30